⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KLRS News
Kalaris Therapeutics, Inc. Common Stock
Kalaris Appoints Laurie Keating to Board of Directors
globenewswire.com
KLRS
PEPG
IMRX
Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling
globenewswire.com
KLRS
Kalaris to Present at Clinical Trials at the Summit 2026
globenewswire.com
KLRS
Form 8-K
sec.gov
KLRS
Kaskela Law LLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. Shareholders and Encourages Investors With Losses to Contact The Firm - KLRS
accessnewswire.com
KLRS
Form 8-K
sec.gov
KLRS
Kalaris Reports First Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
KLRS
Form 8-K
sec.gov
KLRS
Form 8-K
sec.gov
KLRS
Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates
globenewswire.com
KLRS